H.-U. Meier-Kriesche

Author

Also Known As

H Meier-Kriesche, H. -U. Meier-Kriesche, H. Meier-Kriesche, H. U. Meier-Kriesche, H.-U Meier-Kriesche, H.-U. Meier-Kriesche, H.U. Meier-Kriesche, Herwig Ulf Meier-Kriesche, Herwig- Ulf Meier-Kriesche, Herwig-Ulf Meier-Kriesche

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Florida University of Michigan Florida College Emory University Bristol-Myers Squibb (United States)

About

H.-U. Meier-Kriesche is an author at University of Florida specializing in medicine, kidney transplant, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	2.4K
2	Public Health	3	3	178
3	Health Sciences	1	1	126
4	Diabetes	1	1	20
5	Economics	1	1	29

H.-U. Meier-Kriesche

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal Kenneth Lamb, Sundus A. Lodhi, H.-U. Meier-Kriesche American Journal of Transplantation UrologyTransplantationCritical ReappraisalKidney TransplantKidney Transplantation	2010	901
Immunosuppression: Evolution in Practice and Trends, 1994–2004 H.-U. Meier-Kriesche, S. Li, Rainer W.G. Gruessner, American Journal of Transplantation Immunosuppressive TherapyImmunologyAutoimmunityImmune SystemImmunomodulation	2006	557
Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial Robert S. Gaston, Bruce Kaplan, T. Shah, American Journal of Transplantation Molecular PharmacologyControlled-dose Mycophenolate MofetilTherapeutic Drug MonitoringOphthalmologyReduced-dose Calcineurin Inhibitors	2009	187
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study Antoine Dürrbach, José Medina‐Pestana, Sander Florman, American Journal of Transplantation	2016	152
Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States Vikas R. Dharnidharka, Kenneth Lamb, Jon A. Gregg, American Journal of Transplantation Ptld RiskTransplantationMedicineSolid Organ TransplantationClinical Epidemiology	2012	128
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies Robert A. Bray, Howard M. Gebel, Robert Townsend, American Journal of Transplantation Transplantation MedicineImmunologyDonor-specific AntibodiesBenefit-ext StudiesImmunotherapy	2018	126
Mycophenolate Mofetil/Sirolimus Compared to Other Common Immunosuppressive Regimens in Kidney Transplantation Titte R. Srinivas, Jesse D. Schold, Giselle Guerra, American Journal of Transplantation TransplantationKidney TransplantKidney TransplantationSolid Organ TransplantationTransplantation Medicine	2007	100
HEPATITIS C ANTIBODY STATUS AND OUTCOMES IN RENAL TRANSPLANT RECIPIENTS H.-U. Meier-Kriesche, Akinlolu Ojo, Julie A. Hanson, Transplantation	2001	93
Value of Posttransplant Antibody Tests in the Evaluation of Patients with Renal Graft Dysfunction Juan C. Scornik, Giselle Guerra, Jesse D. Schold, American Journal of Transplantation	2007	77
The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease Erin Dunbar, M. P. Buzzeo, J. B. Levine, Haematologica	2008	62

Page 1